Fabris Marciéli, Camargo Priscila G, Silva Mariana L, Lima Camilo H S, Albuquerque Magaly G, Rodrigues Carlos R, Nascimento-Júnior Nailton M, Bispo Marcelle L F
Laboratório de Síntese de Moléculas Medicinais (LaSMMed), Departamento de Química, Universidade Estadual de Londrina (UEL), Rodovia Celso Garcia Cid, PR-445, Km 380, Londrina, Paraná 86057-970, Brasil.
Faculdade de Farmácia, Departamento de Fármacos e Medicamentos, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373, Rio de Janeiro, Rio de Janeiro 21941-170, Brasil.
ACS Omega. 2025 May 22;10(21):21795-21812. doi: 10.1021/acsomega.5c01648. eCollection 2025 Jun 3.
Ureases are metalloenzymes found in plants, algae, fungi, and bacteria that are responsible for hydrolyzing urea into carbamate and ammonia. The bacterium Helicobacter pylori, which is associated with gastrointestinal disorders, produces large amounts of urease to neutralize stomach acidity. The rising antibiotic resistance of H. pylori presents a significant challenge for eradication efforts, highlighting the need for novel therapeutic strategies. In this study, we explored the LaSMMed chemical library to identify new urease inhibitors. Virtual screening identified six thioureas derived from cinnamic acid (), demonstrating urease inhibition rates ranging from 13% to 82%. The most potent compound, (% = 82%), was selected as a lead structure for designing a new series of arylthioureas (. These derivatives exhibited impressive inhibitory activity, with 84% and 88% inhibition rates. Their IC values ranged from 0.464 to 0.575 mM, and their inhibition constants (ki) were between 0.080 and 0.130 mM, indicating competitive inhibition for and mixed-type inhibition for and . Molecular modeling studies provided insights into the structure-activity relationships and potential binding interactions, supporting their role as promising candidates for the development of new urease-targeting agents.
脲酶是存在于植物、藻类、真菌和细菌中的金属酶,负责将尿素水解为氨基甲酸酯和氨。与胃肠道疾病相关的幽门螺杆菌会产生大量脲酶以中和胃酸。幽门螺杆菌不断上升的抗生素耐药性给根除工作带来了重大挑战,凸显了对新型治疗策略的需求。在本研究中,我们探索了LaSMMed化学文库以鉴定新的脲酶抑制剂。虚拟筛选确定了六种源自肉桂酸的硫脲,其脲酶抑制率在13%至82%之间。最有效的化合物(抑制率 = 82%)被选为设计一系列新的芳基硫脲()的先导结构。这些衍生物表现出令人印象深刻的抑制活性,抑制率分别为84%和88%。它们的IC值范围为0.464至0.575 mM,抑制常数(ki)在0.080至0.130 mM之间,表明对 呈竞争性抑制,对 和 呈混合型抑制。分子建模研究深入了解了构效关系和潜在的结合相互作用,支持它们作为开发新型脲酶靶向剂的有前途候选物的作用。